Lars M König

8PUBLICATIONS
65CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunityMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 22, 2026
RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma.

Anne Marie Senz, Bruno L Cadilha, Julia Teppert

|Jul 17, 2021
OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosis.

Daniel F R Boehmer, Simone Formisano, Carina C de Oliveira Mann

|Jun 19, 2021
Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency.

Thomas Magg, Tsubasa Okano, Lars M Koenig

|Jun 04, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours.

Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber

|May 26, 2020
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.

Philipp Metzger, Sabrina V Kirchleitner, Daniel F R Boehmer

Pageof 2